Niagen Bioscience, Inc.

Niagen Bioscience, Inc. develops and commercializes products focused on healthy aging, with nicotinamide riboside (NR) as its flagship ingredient. The company markets NR under the NIAGEN brand name as a nicotinamide adenine dinucleotide (NAD+) precursor. The company operates through three business segments: consumer products, ingredients, and analytical reference standards and services.

The consumer products segment includes finished dietary supplements containing proprietary ingredients sold direct-to-consumer through the company's e-commerce platform TruNiagen.com, as well as through Amazon, ShopHQ, and other online marketplaces and specialty retailers. The ingredients segment supplies food-grade and pharmaceutical-grade NIAGEN as raw materials to manufacturers of consumer products. The analytical reference standards and services segment provides phytochemical reference standards and research and development services. The company also offers NAD+ test kits to healthcare practitioners.

Niagen Bioscience operates with approximately 104 full-time employees and is headquartered in Los Angeles, California. The company distributes primarily throughout the United States, reaching consumers and healthcare practitioners through its direct channels as well as specialty retailers and third-party e-commerce platforms. The company was formerly known as ChromaDex Corporation and rebranded to Niagen Bioscience in March 2025.